Infliximab: Difference between revisions
Jump to navigation
Jump to search
(CSV import) |
(CSV import) |
||
| Line 1: | Line 1: | ||
{{Definitions | {{Definitions | ||
|Term=Infliximab | |Term=Infliximab | ||
|Short definition= | |Short definition=Infliximab (in-FLIK-sih-mab) A monoclonal antibody that blocks the action of a cytokine called tumor necrosis factor alfa. It is being studied to treat and prevent weight loss and loss of appetite in patients with advanced cancer. | ||
|Type=Cancer terms | |Type=Cancer terms | ||
|Specialty=Oncology | |Specialty=Oncology | ||
Latest revision as of 23:55, 11 January 2023
| Infliximab | |
|---|---|
| Term | Infliximab |
| Short definition | Infliximab (in-FLIK-sih-mab) A monoclonal antibody that blocks the action of a cytokine called tumor necrosis factor alfa. It is being studied to treat and prevent weight loss and loss of appetite in patients with advanced cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Infliximab - (pronounced) (in-FLIK-sih-mab) A monoclonal antibody that blocks the action of a cytokine called tumor necrosis factor alfa. It is being studied to treat and prevent weight loss and loss of appetite in patients with advanced cancer. It belongs to the family of monoclonal antibodies
External links
- Medical encyclopedia article on Infliximab
- Wikipedia's article - Infliximab
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski